Low efficacy partial agonists of the α4β2 nicotinic acetylcholine receptor (nAChR). Does functional efficacy govern in vivo response?
Jotham W. Coe, Paige R. Brooks, Michael C. Wirtz, Michael G. Vetelino, Eric P. Arnold, Steven B. Sands, Thomas I. Davis, Lorraine A. Lebel, Carol B. Fox, Alka Shrikhande, Robert S. Mansbach, Leslie K.Volume:
78
Année:
2009
Langue:
english
DOI:
10.1016/j.bcp.2009.06.078
Fichier:
PDF, 56 KB
english, 2009